The balance of Th1 (eg,) and Th2 (eg, 
The balance between the production of pro-inflammatory (eg, IL-2 and interferon-␥) and anti-inflammatory (eg, IL-4 and IL-10) cytokines produced by CD4 T cells can have profound effects on the outcome of infection, cancer, and autoimmunity. [1] [2] [3] The mechanisms underlying the control of Th1 vs Th2 cytokine gene expression by CD4 T cells have been the subject of intense study. 4 The expression of IL-2 and IL-4 by activated CD4 T cells is primarily controlled at the level of transcription, 5 but the molecular mechanisms by which differential transcription is achieved remain only partly understood. Recently, data from several studies, including various transcription factor knock-out and transgenic mice, have implicated roles for STAT4 and 6, c-Maf, NIP45, GATA-3, JunB, CIITA, NFAT1 and 2, C/EBP␤, Bcl-6, SKAT-2, T-bet, ERM, and Mel-18 transcription factors in the transcriptional regulation of Th1 vs Th2 cytokine expression. 4, [6] [7] [8] [9] It has been known for some time that the ubiquitous, Oct-1, and the inducible, Oct-2, octamer transcription factors are capable of increasing transcription of the IL-2 gene in T cells by binding to cis-elements in the proximal IL-2 promoter. 10 However, the role of octamer transcription factors in differential cytokine expression remains unclear.
A putative octamer binding site was first identified in the proximal 5Ј flank region of the human IL-4 gene by Arai and colleagues as part of the initial cloning and sequencing of the human IL-4 genetic locus. 11 This site is located at −68 to −61 with respect to the transcription start site, and is between two critical cis-acting elements, P0 and P1, that bind NFAT proteins. 11, 12 This site is hereafter referred to as the proximal octamer site. The role of octamer transcription factors in IL-4 gene transcription remains controversial. In 1994, Pfeuffer and colleagues confirmed earlier findings that octamer proteins were critical for optimal IL-2 transcription. 13 They also reported that octamer transcription factors appeared not to be involved in the induction of IL-4 promoter activity in thymoma cell lines, since their binding in vitro to the proximal octamer binding site was suppressed by binding of NFAT proteins to nearby sites. 13 In contrast, a more recent study by Li-Weber et al 14 suggested that octamer proteins participated in IL-4 transcription in murine, but not human, Th2 clones. Additionally, the same group has recently suggested that the proximal octamer binding site in the IL-4 promoter may function as a CD28 responsive element by binding AP-1 and NFB transcription factor proteins. 15 Using in vivo footprinting to study the transcription factors bound to the coding strand of the IL-4 proximal promoter in vivo, we confirmed our previous results from the non-coding strand. 12 Specifically, the proximal octamer binding site was protected from methylation in unstimulated (resting) (Figure 1 , 77% decrease in band (᭜) intensity compared to the in vitro control) but not in stimulated (activated) human CD4 effector T cells ( Figure  1 , only 13% decrease in band (᭜) intensity). This was true for ionomycin alone, a stimulus capable of activating NFAT and allowing for its translocation to the nucleus. 16 This suggested that protein was bound to the proximal octamer site prior to activation. Furthermore, subsequent IL-4 production was associated with loss of protein binding (de-protection) of the proximal octamer binding site (Figure 1 ). We previously demonstrated that after polyclonal stimulation of the effector CD4 T cells the neighboring NFAT sites were bound at the precise residues (5ЈGGA) on the non-coding strand (AG rich for P0 and P1) 12 where NFAT has been definitively shown to bind DNA. 17 During the same activation time-frame (2 h), the proximal octamer site sandwiched between the NFAT bound P0 and P1 sites became de-protected on both the non-coding 12 and coding strands ( Figure 1 ), suggesting loss of protein binding to the proximal octamer site while IL-4 was being transcribed. 12 The precise guanosine residue protected on the IL-4 promoter's coding strand ( Figure 1 , top diamond) corresponds to the guanosine residue of the ATGC subsite shown by crystal structure analysis to be a contact residue of the POU-specific domain of Oct-1. 18 These results are consistent with those of Pfeuffer and colleagues 13 in suggesting that NFAT and octamer proteins compete for binding to the same region of the IL-4 proximal promoter. Moreover, in vitro footprinting using T cell extracts obtained before and after activation has revealed a similar mechanism of octamer inhibition of IL-5 gene transcription with octamer sites protected before, but not after, activation. 19 Based on the in vivo footprints described above, we hypothesize that octamer transcription factors may actually inhibit NFAT binding to the proximal NFAT binding sites, P0 and P1, and, thus, negatively regulate IL-4 gene transcription in primary human CD4 T cells.
Earlier, we showed that NFAT proteins from activated primed human CD4 T cells bound to an oligonucleotide containing the P1 element alone. 12 By contrast, we were unable to detect NFAT binding using similar nuclear extracts and a probe containing both the P1 NFAT site and the neighboring octamer site (Figure 2a, lane 3) . This was the case even in the presence of the upstream OAP site that binds AP-1 proteins and cooperates with NFAT in binding. 20 However, pre-incubation of the nuclear extract with a cold competitor oligonucleotide corresponding to the proximal octamer site alone allowed for protein binding (Figure 2a, lane 4) . Two complexes were identified, both of which contained NFAT1 and NFAT2 proteins as demonstrated by inhibition by antibodies specific for NFAT1 and NFAT2 (Figure 2b, lanes 2, 3) but not control rabbit antisera (data not shown). The upper complex was less inhibited than the lower complex and most likely represents composite NFAT and AP-1 factors as has been shown by others. 20 This suggested that NFAT was only able to bind in the absence of neighboring octamer binding.
We next wished to analyze the importance of the octamer site functionally. We have previously demonstrated that both of the most proximal NFAT binding sites, P0 and P1, are independently critical for optimal IL-4 gene Genes and Immunity
Figure 1
In vivo footprint of the proximal octamer binding site of the human IL-4 promoter. The coding strand of the proximal octamer binding site and flanking sequences were in vivo footprinted in resting and activated (treatment with 1.5 M ionomycin) effector human CD4 T cells as previously described. 12 The following nested primers and respective annealing temperatures were used during PCR amplification: primer 315 (5Ј-AAGGTTTCATTTTCCTA TTGGTC), 55°C; primer 316 (5Ј-GGTCTGATTTCACAGGAA CATTTTACTG), 60°C; primer 317 (5Ј-GGTCTGATTTCACAGG AACATTTTACCTGTTTGTGAG), 63°C. The A/G cleavage pattern for genomic DNA is presented for comparison (in vitro). The corresponding coding strand sequence is listed below the footprints, with the NFAT sites underlined and the octamer site enclosed in brackets. The protected and de-protected octamer binding residue is depicted by a diamond at the top. The octamer binding residues protected and de-protected, from the analysis of the non-coding strand, 12 are denoted by the lower diamonds, and the protected NFAT binding residues after activation are denoted by arrows. The octamer mutant coding strand sequence, used in the luciferase reporter gene, pIL-4-Octm-Luc (Figures 3 and 4) , is depicted below the wild-type sequence with the mutated residues underlined. Below, a model depicts results of in vivo footprinting of the coding and non-coding strands of the human IL-4 proximal promoter in primed effector human CD4 T cells, which revealed protein engagement of the octamer binding site (Oct) prior to activation (resting state). 12 After activation, protein binding was detected for the corresponding GGA (NFAT binding) residues of both P0 and P1 sites, while the Oct site lost protein engagement (activated state). 12 Band intensity was determined by densitometry using the NIH software program, Image 1.49. , lanes 3, 4, and b, lanes 1-3) before nuclei were harvested. Nuclear extracts were prepared as previously described. 12 A singlestranded oligonucleotide corresponding to the proximal IL-4 promoter OAP (AP-1)/P1 (NFAT)/Octamer site (5Ј CTGGTGTAA CGAAAATTTCCAATGTAAACTCA) was 5Ј end-labeled with [␥-32 P]ATP using T4-polynucleotide kinase, annealed to its partner strand, and purified. For each binding reaction, radiolabeled probe (1 × 10 4 cpm, 0.1 ng) was incubated with nothing (a, lane 1) or 1 g of nuclear extract (a, lanes 2-4, and b, lanes 1-3) in binding buffer for 10 min at room temperature. Samples were then analyzed by electrophoresis on pre-cast 6% polyacrylamide gels (Novex, San Diego, CA, USA) in 0.3 × TBE. To allow for NFAT binding, the nuclear extracts were pre-incubated with 100-fold excess of a cold oligonucleotide competitor corresponding to the octamer binding site, 5ЈCCAATGTAAACTCA, for 10 min at room temperature before addition of the radiolabeled probe (a, lane 4, and b, lanes 1-3). In addition, 1 l of anti-NFAT1 (67.1) (b, lane 2) or anti-NFAT2 (7A6, Santa Cruz Biotechnology, Santa Cruz, CA, USA) (b, lane 3) antibody was added 10 min prior to addition of radiolabeled probe. Free probe is noted at the bottom of the gels. transcription in normal human CD4 T cells. 12 Moreover, mutation of the upstream NFAT binding element, P3, within the human IL-4 promoter reporter gene, generating pIL-4-P3m-Luc, demonstrates the importance of a more distal NFAT binding site to optimal IL-4 gene transcription in normal human CD4 T cells (Figure 3 ). Together these results suggest that the simultaneous engagement of multiple NFAT binding sites is required for optimal IL-4 promoter activity in human CD4 T cells. Similar results have been reported in analyzing the murine IL-4 promoter NFAT binding sites. 21 These results also suggest that limitations in the accessibility of any of these P element sites for NFAT protein binding would be expected to decrease IL-4 promoter activity. Our data suggests the possibility that proteins bound to the proximal octamer binding site might interfere in a steric manner with NFAT binding to adjacent P elements. An IL-4 promoter-directed reporter gene construct (pIL-4-Octm- Figure  1 ). The cells were co-transfected with 1 g of pRL-null (Renilla luciferase reporter gene; Promega, Madison, WI, USA) to correct for transfection efficiency. 27 The cells were then activated in vitro for 6 h with PMA (25 ng/ml) and ionomycin (1.5 M) as previously described. 12 Luciferase activity is plotted on the y-axis after correction for transfection efficiency. Means ± s.e.m. from one representative experiment of seven are presented. Site-directed mutants were generated as previously described. 12 Luc) was prepared in which the proximal octamer binding site was mutated by substitution to ablate octamer binding (see Figure 1) . The transcriptional activity of pIL-4-Octm-Luc in polyclonally-stimulated human CD4 effector T cells was significantly augmented relative to the wild-type IL-4 promoter (Figure 3 ). This suggests that disruption of protein binding to the proximal octamer binding site of the IL-4 promoter acts to enhance IL-4 gene transcription by activated CD4 T cells. Similarly, disruption of octamer binding by substitution mutations in the proximal octamer binding region of a human IL-5 promoter reporter gene significantly increased IL-5 promoter activity in activated T cells. 19 To directly analyze the role of octamer transcription factors on cytokine promoter activity in primary human CD4 T cells, freshly-isolated human CD4 T cells were transiently transfected with reporter genes directed by either the wild-type IL-2 or wild-type IL-4 promoters, and co-transfected with Oct-1 or Oct-2 expression vectors. 22 After polyclonal stimulation in vitro for 6 h, reporter gene analysis revealed that increased expression of either Oct-1 or Oct-2 led to increased IL-2 promoter activity (Figure 4 ), in agreement with previous reports. 10, 13 In contrast, increased expression of either Oct-1 or Oct-2 substantially inhibited wild-type IL-4 promoter activity in primary human CD4 T cells (Figure 4 ). Ten g of octamer expression plasmids, 22 pCG-Oct1 (Oct-1), pCGOct2 (Oct-2), or pCG (parent control vector), were co-transfected along with 1 g of pRL-null to correct for transfection efficiency. 27 Cells were stimulated with PMA and ionomycin for 6 h in vitro, and corrected luciferase activity is plotted, on a log 10 scale, as fold induction by the particular octamer expression plasmid (pCG-Oct1 or 2) vs its parent control (pCG). Means of duplicate samples from one representative experiment of three are presented.
Similarly, transcriptional repression of the HIV-1 long terminal repeat promoter has been demonstrated after increased expression of either Oct-1 or Oct-2 in fibroblasts. 23 The effect of Oct-1 and Oct-2 was next analyzed using the IL-4 promoter octamer site mutant, pIL-4-Octm-Luc. Both Oct-1 and Oct-2 had minimal effects, if any, on octamer site-mutated IL-4 promoter activity in stimulated primary human CD4 T cells (Figure 4 ). This argues that the repressive effects of octamer proteins on IL-4 promoter activity occur via interaction with the proximal octamer binding site rather than at other potential octamer binding sites located further 5Ј of the transcriptional start site. 11, 24 Consistent with our in vivo footprint results (Figure 1) , 12 and the in vitro binding data from Pfeuffer and colleagues, 13 octamer proteins appear to inhibit IL-4 gene transcription by interfering with NFAT binding to the proximal IL-4 promoter. Similar results have been shown for Oct-1 interference with nearby binding of the Genes and Immunity transcription factor, C/EBP, to the IL-8 promoter, resulting in repression of IL-8 gene transcription. 25 Together, these results suggest that octamer binding proteins may act as steric inhibitors of the assemblage of transcriptional activator proteins required for the transcription of certain cytokine and chemokine genes. This steric regulatory mechanism is in addition to other wellcharacterized mechanisms by which octamer proteins may either act as transcriptional activators or repressors, depending on alternative RNA splicing of their transcript, post-translational modification, or their association with co-activator proteins. 26 In summary, site-directed mutation of the Oct site in the proximal IL-4 promoter reporter gene (pIL-4-OctmLuc) results in increased transcriptional activity relative to the wild-type IL-4 promoter construct, pIL-4-Luc, in primary human CD4 T cells. The octamer site mutation, unlike NFAT binding site mutants, is the only reported transcription factor binding site mutant that clearly enhances IL-4 promoter activity. Both exogenous Oct-1 and Oct-2 markedly increase IL-2 promoter activity while decreasing IL-4 promoter activity in freshly-isolated human peripheral blood CD4 T cells. Moreover, neither Oct-1 or Oct-2 expression plasmids are capable of decreasing transcriptional activity of the Oct mutant IL-4 promoter reporter gene, pIL-4-Octm-Luc. Thus, the transcription factors, Oct-1 and Oct-2, appear to decrease IL-4 transcription, via interaction with the proximal octamer site located between the IL-4 promoter proximal NFAT binding sites, P0 and P1, while enhancing IL-2 gene transcription. Octamer protein(s) bound to the IL-4 promoter may prevent the small amount of nuclear NFAT protein present in effector CD4 T cells prior to activation 12 from binding to the P0 and P1 sites. The octamer proteins, therefore, are candidates to promote a Th1 (IL-2) rather than a Th2 (IL-4) pattern of cytokine gene expression in human CD4 T cells.
